Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SHANT BIOTECH from Tubize, company number BE0680795389, closed financial year 2025 with a result of € -201,509 after tax. For that financial year SHANT BIOTECH recorded a gross margin of € -178,118 and equity of € 10.4 million. Compared with financial year 2024, the result moved from € -153,611 to € -201,509. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 10.4 million
▲ € 11 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -201,509
▼ 31 % more loss than in 2024
Profit after tax over the fiscal year.
€ 1.5 million
▲ 175% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -799,328.
People and assets in 2025
€ 72,311
▲ € 69,936 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 200,000
▼ 98% vs 2024
Loans from banks and other lenders, long and short.
€ 413,451
▲ 62% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 572
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -59,105 | € -98,690 | € -147,705 | € -178,118 | ▼ € 30,413 |
| Profit after taxes | € -74,783 | € -106,163 | € -153,611 | € -201,509 | ▼ € 47,899 |
| Equity | € -279,160 | € -385,323 | € -538,934 | € 10,423,060 | ▲ € 11 million |
| Total debts | € 6,579,769 | € 8,516,503 | € 9,863,398 | € 614,035 | ▼ 94% |
| Cash | € 276,345 | € 282,814 | € 545,927 | € 1,501,118 | ▲ 175% |
| Land & buildings | € 5,965,285 | € 7,828,568 | € 8,675,286 | € 9,283,398 | ▲ 7% |
| Retained profit | € -343,160 | € -449,323 | € -602,934 | € -799,328 | ▼ € 196,394 |
| Bank debt | € 6,218,388 | € 8,228,388 | € 9,608,388 | € 200,000 | ▼ 98% |
| Balance sheet total | € 6,300,609 | € 8,131,179 | € 9,324,464 | € 11,037,094 | ▲ 18% |
Key figures of SHANT BIOTECH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SHANT BIOTECH?
What happened at SHANT BIOTECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- GAGIK ABRAHAMYAN stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 201,509. filed late Source: NBB ↗
- New establishment in Enghien. KBO
- GAGIK ABRAHAMYAN became a director. NBB
- New establishment in Tubize. KBO
- Start of the company according to the CBE. KBO
In short
From € 74,783 loss in 2022 to € 201,509 loss in 2025.
Paid € 2,240 in corporate taxes since 2022.
A new publication or filing at SHANT BIOTECH? We notify you, reason included.
Follow SHANT BIOTECHDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
GAGIK ABRAHAMYAN
Managing director
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Avenue Léon Champagne 2
1480 Tubize
Ilya Prigoginestraat 4
7850 Enghien
Active since 23 October 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →PYRINDUS
€ 55,013 gross margin · 2025
D.C.
€ 177,523 gross margin · 2025
UNION DES ENTREPRISES POUR LE DEVELOPPEMENT DE L'OUEST DU BRABANT WALLON
SHANT LABORATORIES BELGIUM
€ 3,404 gross margin · 2025
L'AGE D'OR SERVICES BRABANT - OUEST
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0680.795.389
- VAT number
- BE 0680.795.389
- Registered office
- Avenue Léon Champagne 2, 1480 Tubize
- Names & denominations
- SHANT BIOTECH
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 September 2017
- Peppol
- Active · Active since 21 Oct 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van farmaceutische grondstoffen